Standard Biotools (LAB) Total Liabilities (2016 - 2025)
Standard Biotools (LAB) has disclosed Total Liabilities for 16 consecutive years, with $143.5 million as the latest value for Q4 2025.
- Quarterly Total Liabilities rose 2.02% to $143.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $143.5 million through Dec 2025, up 2.02% year-over-year, with the annual reading at $143.5 million for FY2025, 2.02% up from the prior year.
- Total Liabilities for Q4 2025 was $143.5 million at Standard Biotools, up from $140.0 million in the prior quarter.
- The five-year high for Total Liabilities was $249.8 million in Q1 2022, with the low at $125.0 million in Q1 2025.
- Average Total Liabilities over 5 years is $168.9 million, with a median of $163.5 million recorded in 2022.
- The sharpest move saw Total Liabilities soared 37.07% in 2022, then tumbled 37.61% in 2025.
- Over 5 years, Total Liabilities stood at $180.6 million in 2021, then dropped by 11.13% to $160.5 million in 2022, then dropped by 0.41% to $159.9 million in 2023, then decreased by 12.04% to $140.6 million in 2024, then rose by 2.02% to $143.5 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods came in at $143.5 million, $140.0 million, and $132.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.